Role of Probiotics in SARS-CoV-2 Infection: Review of Evidence
Interspecies transmission of viruses between animals and humans could lead to infections of severe pathogenic potential and cause transmissible diseases of unpredictable clinical outcomes. This situation has been well exemplified by the discovery of new pathogenic viruses, such as the novel severe acute respiratory syndrome corona virus-2 (SARS-CoV-2), which continues to have a massive global impact in terms of economic disruption, and, above all, human health.
While the development of the vaccine is still some time away, and new antiviral agents require a considerable length of time and effort for drug design and validation. While our endeavour to repurpose existing agents continue, it may be borne in mind to consider the regulatory role of probiotics on gut-lung axis, as we briefly review the prophylactic and supportive role of probiotics for the management of COVID-19 as immune response modifying agents (1)
Dr Kamal Kant Kohli-MBBS, DTCD- a chest specialist with more than 30 years of practice and a flair for writing clinical articles, Dr Kamal Kant Kohli joined Medical Dialogues as a Chief Editor of Medical News. Besides writing articles, as an editor, he proofreads and verifies all the medical content published on Medical Dialogues including those coming from journals, studies,medical conferences,guidelines etc. Before Joining Medical Dialogues, he has served at important positions in the medical industry in India including as the Hony. Secretary of the Delhi Medical Association as well as the chairman of Anti-Quackery Committee in Delhi and worked with other Medical Councils in India. Email: firstname.lastname@example.org. Contact no. 011-43720751